Dentsply Sirona

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell XRAY and other ETFs, options, and stocks.

About XRAY

Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. 

CEO
Daniel T. Scavilla
CEODaniel T. Scavilla
Employees
14,000
Employees14,000
Headquarters
Charlotte, North Carolina
HeadquartersCharlotte, North Carolina
Founded
1899
Founded1899
Employees
14,000
Employees14,000

XRAY Key Statistics

Market cap
2.55B
Market cap2.55B
Price-Earnings ratio
-4.25
Price-Earnings ratio-4.25
Dividend yield
5.02%
Dividend yield5.02%
Average volume
6.80M
Average volume6.80M
High today
$13.25
High today$13.25
Low today
$12.31
Low today$12.31
Open price
$13.04
Open price$13.04
Volume
5.04M
Volume5.04M
52 Week high
$17.18
52 Week high$17.18
52 Week low
$9.85
52 Week low$9.85

Stock Snapshot

With a market cap of 2.55B, Dentsply Sirona(XRAY) trades at $12.70. The stock has a price-to-earnings ratio of -4.25 and currently yields dividends of 5.0%.

On 2026-03-08, Dentsply Sirona(XRAY) stock traded between a low of $12.31 and a high of $13.25. Shares are currently priced at $12.70, which is +3.2% above the low and -4.1% below the high.

The Dentsply Sirona(XRAY)'s current trading volume is 5.04M, compared to an average daily volume of 6.8M.

In the last year, Dentsply Sirona(XRAY) shares hit a 52-week high of $17.18 and a 52-week low of $9.85.

In the last year, Dentsply Sirona(XRAY) shares hit a 52-week high of $17.18 and a 52-week low of $9.85.

XRAY News

Simply Wall St 23h
Dentsply Sirona Broadens US Reach As Board Refresh Shapes Growth Story

Dentsply Sirona (NasdaqGS:XRAY) expanded its partnership with Burkhart Dental Supply to distribute its full technology portfolio across the US. The company als...

Dentsply Sirona Broadens US Reach As Board Refresh Shapes Growth Story
Simply Wall St 4d
DENTSPLY SIRONA Is Up 5.0% After Impairment Charges And New Guidance Reset Expectations – What’s Changed

DENTSPLY SIRONA recently reported fourth-quarter 2025 results showing sales of US$961 million and a net loss of US$146 million, recorded sizeable non-cash impai...

DENTSPLY SIRONA Is Up 5.0% After Impairment Charges And New Guidance Reset Expectations – What’s Changed
Nasdaq 4d
Wednesday 3/4 Insider Buying Report: XRAY, PVLA

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at tw...

Wednesday 3/4 Insider Buying Report: XRAY, PVLA

Analyst ratings

78%

of 18 ratings
Buy
16.7%
Hold
77.8%
Sell
5.6%

More XRAY News

Nasdaq 4d
Top Buys by Directors: Lucier's $707.4K Bet on XRAY

The directors of a company tend to have a unique inside view into the business, so when directors make major buys, investors are wise to take notice. Presumably...

Top Buys by Directors: Lucier's $707.4K Bet on XRAY
TipRanks 7d
Dentsply Sirona price target raised to $18 from $16 at UBS

UBS analyst Kevin Caliendo raised the firm’s price target on Dentsply Sirona (XRAY) to $18 from $16 and keeps a Buy rating on the shares. Published first on Th...

People also own

Based on the portfolios of people who own XRAY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.